SOW
CTKB icon

State of Wyoming’s Cytek Biosciences CTKB Stock Holding History

State of Wyoming’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,253
Closed -$53.5K – 1974
2026
Q1 		$53.5K Sell
12,253
-769
-6% -$3.63K 0.01% 1528
2025
Q4 		$65.8K Buy
13,022
+2,268
+21% +$10.5K 0.01% 1472
2025
Q3 		$37.3K Buy
10,754
+1,216
+13% +$4.57K ﹤0.01% 1628
2025
Q2 		$32.4K Sell
9,538
-10,654
-53% -$35.5K ﹤0.01% 1651
2025
Q1 		$81K Sell
20,192
-19,580
-49% -$101K 0.01% 1286
2024
Q4 		$258K Buy
39,772
+11,394
+40% +$67.9K 0.03% 664
2024
Q3 		$157K Buy
28,378
+4,507
+19% +$25.6K 0.02% 860
2024
Q2 		$133K Buy
23,871
+6,233
+35% +$37.4K 0.02% 844
2024
Q1 		$118K Buy
17,638
+4,753
+37% +$37.6K 0.02% 898
2023
Q4 		$118K Buy
12,885
+3,895
+43% +$24.5K 0.02% 885
2023
Q3 		$49.6K Buy
8,990
+4,358
+94% +$35K 0.01% 1241
2023
Q2 		$39.6K Buy
4,632
+2,328
+101% +$20.9K 0.01% 1216
2023
Q1 		$21.2K Buy
2,304
+505
+28% +$5.43K 0.01% 1410
2022
Q4 		$18.4K Buy
+1,799
New +$24.2K 0.01% 1387

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State of Wyoming's CTKB Position: Q2 2026 in Review

State of Wyoming sold out of Cytek Biosciences (CTKB) in Q2 2026, closing a stake of 12,253 shares — an estimated $53.5K sold.

State of Wyoming first reported a position in CTKB in Q4 2022 and held it in 14 quarters. The position peaked at $258K in Q4 2024. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • State of Wyoming reported no remaining Cytek Biosciences position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 12,253 Cytek Biosciences shares in Q2 2026, an estimated $53.5K.
  • State of Wyoming first reported a position in Cytek Biosciences in Q4 2022 and held it in 14 quarters.
  • State of Wyoming's Cytek Biosciences position peaked at $258K in Q4 2024.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.